Effects of thymoquinone - Fatty acid conjugates on cancer cells

ChemMedChem

Volumn 4, Issue 5, 2009, Pages 761-768

  Breyer, Sandra ^a   Effenberger, Katharina ^a   Schobert, Rainer ^a  

^a UNIVERSITY OF BAYREUTH   (Germany)

Author keywords

Antitumor agents; Conjugates; Docosahexaenoic acid; Fatty acids; Thymoquinones

Indexed keywords

6 (3' METHYLBUT 2' ENYL)THYMOQUINONE; 6 (3',7' DIMETHYLOCTA 2,6 DIENYL)THYMOQUINONE; 6 (HENCOSA 3',6',9',12',15',18' HEXAENYL)THYMOQUINONE; 6 (HEPTADECA 8',11' DIENYL)THYMOQUINONE; 6 (HEPTADECA 8',11',14' TRIENYL)THYMOQUINONE; 6 HEPATADECA 8' ENYLTHYMOQUINONE; 6 HEPTADECYLTHYMOQUINONE; ALPHA LINOLENIC ACID HYDRAZIDE; ANTINEOPLASTIC AGENT; CASPASE; FATTY ACID DERIVATIVE; HEXADECANOYLHYDRAZINE; N (ALPHA LINOLENOYL) N' TERT BUTOXYCARBONYLHYDRAZINE; N HEXADECANOYL N' TERT BUTOXYCARBONYLHYDRAZINE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; THYMOQUINONE; THYMOQUINONE 4 ALPHA LINOLENOYLHYDRAZONE; THYMOQUINONE 4 HEXADECANOYLHYDRAZONE; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; DOCOSAHEXAENOIC ACID; FATTY ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CELL STRAIN HL 60; CELL STRAIN MCF 7; CHEMICAL BOND; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; MELANOMA; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; UTERINE CERVIX CANCER; BLACK CUMIN; CHEMISTRY; DRUG SCREENING; METABOLISM; PLANT SEED; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BENZOQUINONES; CASPASES; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; DRUG SCREENING ASSAYS, ANTITUMOR; FATTY ACIDS; HUMANS; NIGELLA SATIVA; REACTIVE OXYGEN SPECIES; SEEDS;

EID: 67651083705     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200800430     Document Type: Article

References (37)

1. M. A. Colucci, C. J. Moody, G. D. Couch, Org. Biomol. Chem. 2008, 6, 637-656.
2. R. El Mezayen, M. El Gazzar, M. R. Nicolls, J. C. Marecki, S. C. Dreskin, H. Nomiyamab, Immunol. Lett. 2006, 106, 72-81.
3. D. Worthen, G. Ghosheh, P. Crooks, Anticancer Res. 1998, 18, 1527-1532.
4. O. A. Badary, A. M. Gamal El-Din, Cancer Detect. Prev. 2001, 25, 362-368.
5. O. A. Badary, O. A. Al-Shabanah, M. N. Nagi, A. C. Al-Rikabi, M. M. Elmazar, Eur. J. Cancer Prev. 1999, 8, 435-440.
6. H. Gali-Muhtasib, A. Roessner, R. Schneider-Stock, Int. J. Biochem. Cell Biol. 2006, 38, 1249-1253.
7. H. Gali-Muhtasib, M. Ocker, D. Kuester, S. Krueger, Z. El-Hajj, A. Diestel, M. Evert, N. El-Najjar, B. Peters, A. Jurjus, A. Roessner, R. Schneider-Stock, J. Cell. Mol. Med. 2008, 12, 330-342.
8. H. Gali-Muhtasib, M. Diab-Assaf, C. Boltze, J. Al-Hmaira, R. Hartig, A. Roessner, R. Schneider-Stock, Int. J. Oncol. 2004, 25, 857-866.
9. M. A. El-Mahdy, Q. Zhu, Q. E. Wang, G. Wani, A. A. Wani, Int. J. Cancer 2005, 117, 409-417.
10. A. M. Shoieb, M. Elgayyar, P. S. Dudrick, J. L. Bell, P. K. Tithof, Int. J. Oncol. 2003, 22, 107-113.
11. H. Gali-Muhtasib, W. Aboukheir, L. Kheir, N. Darwiche, P. Crooks, Anticancer Drugs 2004, 15, 389-399.
12. W. Reindl, J. Yuan, A. Krämer, K. Strebhardt, T. Berg, Chem. Biol. 2008, 15, 459-466.
13. B. H. Ali, G. Blunden, Phytother. Res. 2003, 17, 299-305.
14. a) L. A. Sauer, R. T. Dauchy, Br. J. Cancer 1992, 66, 297-303;
15. b) L. A. Sauer, R. T. Dauchy, D. E. Blask, Cancer Res. 2000, 60, 5289-5295.
16. M. O. Bradley, N. L. Webb, F. H. Anthony, P. Devanesan, P. A. Witman, S. Hemamalini, M. C. Chander, S. D. Baker, L. He, S. B. Horwitz, C. S. Swindell, Clin. Cancer Res. 2001, 7, 3229-3238.
17. Y. Wang, L. Li, W. Jiang, Z. Yang, Z. Zhang, Bioorg. Med. Chem. Lett. 2006, 16, 2974-2977.
18. G. Bernhardt, B. Biersack, S. Bollwein, R. Schobert, M. Zoldakova, Chem. Biodiversity 2008, 5, 1645-1659.
19. R. Schobert, B. Biersack, A. Dietrich, A. Grotemeier, T. Müller, B. Kalinowski, S. Knauer, W. Voigt, R. Paschke, J. Med. Chem. 2007, 50, 1288-1293.
20. A. Takahashi, A. Mallia, N. Tamaoki, J. Mater. Chem. 2003, 13, 1582-1587. DOI: 10.1002/cmdc.200800430
21. P. C. A. Rodrigues, T. Roth, H. H. Fiebig, C. Unger, R. Mülhaupt, F. Kratz, Bioorg. Med. Chem. 2006, 14, 4110-4117.
22. C. C. Lee, A. T. Cramer, F. C. Szoka, Jr., J. M. J. Fréchet, Bioconjugate Chem. 2006, 17, 1364-1368.
23. T. Kaneko, D. Willner, I. Monkvíc, J. O. Knipe, G. R. Braslawsky, R. S. Greenfiled, D. M. Vyas, Bioconjugate Chem. 1991, 2, 133-141.
24. A. A. Avetissian, G. G. Tokmajian, V. V. Karapetian, Chem. Heterocycl. Compd. 2005, 41, 835-840.
25. N. Jacobsen, K. Torssell, Justus Liebigs Ann. Chem. 1972, 763, 135-147.
26. R. Jockers, R. D. Schmid, H. Rieger, K. Krohn, Liebigs Ann. Chem. 1991, 315-321.
27. K. Mori, Y. Funaki, Tetrahedron 1985, 41, 2369-2377.
28. A. van der Klei, R. L. P. de Jong, J. Lugtenburg, A. G. M. Tielens, Eur. J. Org. Chem. 2002, 3015-3023.
29. Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 1992, 119, 493-501.
30. W. C. Earnshaw, L. M. Martins, S. C. Kaufmann, Annu. Rev. Biochem. 1999, 68, 383-424.
31. I. Budihardjo, H. Oliver, M. Lutter, X. Luo, X. Wang, Annu. Rev. Cell Dev. Biol. 1999, 15, 269-290.
32. L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, C. A. Stein, Clin. Cancer Res. 2004, 10, 8371-8379.
33. C. N. Kim, X. Wang, Y. Huang, A. M. Ibrado, L. Liu, G. Fang, K. Bhalla, Cancer Res. 1997, 57, 3115-3120.
34. S. Desagher, A. Osen-Sand, A. Nicholas, R. Eskes, S. Montessuit, J. Cell Biol. 1999, 144, 891-901.
35. U. N. Das, M. E. Begin, G. Ells, Y. S. Huang, D. F. Horobin, Biochem. Biophys. Res. Commun. 1987, 145, 15-24.
36. G. A. W. Rook, J. Steele, S. Umar, H. M. J. Dockrell, J. Immunol. Methods 1985, 82, 161-167.
37. T. Berg, R. Schobert, W. Reindl, S. Breyer, K. Effenberger, unpublished results.